SER-109
Seres Therapeutics
['$mcrb', 'seres therap']
seres therapeutics and nestl health science present results from ecospor iv phase 3 study of vowst , a microbiota-based oral therapeutic for prevention of recurrence of c. difficile infection, at the digestive disease week (ddw) annual meeting $mcrb 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2